Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Radka Stoyanova et al.|Molecular Cancer Therapeutics|2016Cited by 20
Supplementary Figure S2: ATF3 knockdown via siATF3 inhibits apoptosis in VCaP cells after AD and edelfosine treatment. from Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Radka Stoyanova et al.|Unknown|2023Cited by 0
Supplementary Figure S1: Edelfosine and ADT inhibits cell proliferation in VCaP cells. from Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Radka Stoyanova et al.|Unknown|2023Cited by 0
Supplementary Figure Legends from Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Radka Stoyanova et al.|Unknown|2023Cited by 0
Supplementary Figure S5: Elevated ATF3 after AD and edelfosine treatments inhibits AR promoter activity in LNCaP cells. from Edelfosine Promotes Apoptosis in Androgen-Deprived Prostate Tumors by Increasing ATF3 and Inhibiting Androgen Receptor ActivityThirupandiyur S. Udayakumar, Alan Pollack, Sakhi Philip et al.|Unknown|2023Cited by 0